Feature Channels:

Immunology

Add to Favorites Subscribe Share
fbshare-Immunology

Showing results

110 of 1684
Embargo will expire:
17-Jun-2019 11:00 AM EDT
Released to reporters:
14-Jun-2019 8:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 17-Jun-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
17-Jun-2019 11:00 AM EDT
Released to reporters:
13-Jun-2019 11:30 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 17-Jun-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
18-Jun-2019 9:00 AM EDT
Released to reporters:
12-Jun-2019 9:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 18-Jun-2019 9:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Molecular Chatter Makes for a “Hot Tumor”

Article ID: 714127

Molecular Chatter Makes for a “Hot Tumor”

Ludwig Cancer Research

A Ludwig Cancer Research study has deciphered a complex molecular conversation between cancer and immune cells that is key to orchestrating the successful invasion of tumors by T cells that kill cancer cells.

Released:
10-Jun-2019 11:00 AM EDT

Article ID: 714147

Study Drug Delays Type 1 Diabetes in High Risk Children and Adults

Vanderbilt University Medical Center

A drug that targets the immune system can delay the onset of type 1 diabetes an average of two years in children and adults at high risk, according to findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study published in the New England Journal of Medicine.

Released:
10-Jun-2019 9:45 AM EDT
Newswise: Is sex primarily a strategy against transmissible cancer?
  • Embargo expired:
    6-Jun-2019 2:00 PM EDT

Article ID: 713537

Is sex primarily a strategy against transmissible cancer?

PLOS

One of the greatest enigmas of evolutionary biology is that while sex is the dominant mode of reproduction among multicellular organisms, asexual reproduction appears much more efficient and less costly.

Released:
28-May-2019 9:00 AM EDT
GWU_logo.png

Article ID: 714036

Sanjay B. Maggirwar, PhD, MBA, to Chair the GW Department of Microbiology, Immunology, and Tropical Medicine

George Washington University

Sanjay B. Maggirwar, PhD, MBA, has been selected to serve as chair of the Department of Microbiology, Immunology, and Tropical Medicine at the George Washington University School of Medicine and Health Sciences

Released:
6-Jun-2019 12:05 PM EDT
Newswise: UCLA researchers identify three-drug combination that helps curb the growth of deadly type of skin cancer
  • Embargo expired:
    6-Jun-2019 11:00 AM EDT

Article ID: 713970

UCLA researchers identify three-drug combination that helps curb the growth of deadly type of skin cancer

University of California, Los Angeles (UCLA), Health Sciences

A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.

Released:
5-Jun-2019 12:15 PM EDT
hms-logo.gif

Article ID: 714024

Harvard Medical School Announces 2019 Media Fellowships

Harvard Medical School

Harvard Medical School’s Media Fellowship program, now entering its 22nd year, is accepting applications for Fall 2019.

Released:
6-Jun-2019 10:05 AM EDT

Education

Newswise: To Fight TB Infection, Early Protection Is Crucial
  • Embargo expired:
    5-Jun-2019 1:00 PM EDT

Article ID: 713943

To Fight TB Infection, Early Protection Is Crucial

Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis and the Africa Health Research Institute have identified a master cell that coordinates the body’s immune defenses in the crucial early days after infection. Boosting the activity of such cells could help reduce the millions of new infections that occur worldwide every year.

Released:
4-Jun-2019 4:05 PM EDT

Showing results

110 of 1684

Chat now!